19 Jul Allarta Life Science
Harald Stover, Ph.D., CEO
Oct. 7 | 2:30pm | FLW Ballroom G
Hamilton, Canada
(Private)
Allarta Life Science is a Canadian regenerative medicine company, founded in 2019 by McMaster’s Chemistry Professor Dr. Harald Stover and Maria Antonakos. Allarta’s unique platform of synthetic hydrogel technology is enabled by 30+ years of foundational expertise and its modular design advances next generation cell therapies. Allarta’s hydrogels allow transplanted cells to connect metabolically while protecting them from the host’s immune system, both key requirements for allogeneic cell therapies. Allarta aims to deliver functional cell-based cures for inflammatory and metabolic disorders, including diabetes, without the need for immune suppression. In 2023, Allarta entered an IDDP partnership with Breakthrough T1D (formerly JDRF) to conduct key pre-clinical studies towards its cell-based therapy. In addition, Allarta develops proprietary cryoprotective gels that prevent cell aggregation and minimize ice crystal formation, and thus help ensure delivery of high value cell payloads at scale. This novel technology offers safe transportation and cryostorage of therapeutic cell products.
